Myriad Genetics Inc
MYGN
Revenue
211.50M
▲9.30M▲4.60%
3 Months ChangeAssets
1.09B
▼-25.40M▼-2.29%
3 Months ChangeLiabilities
344.60M
▼-5.90M▼-1.68%
3 Months ChangeFree Cash Flow
-56.70M
▼-3.90M▼-7.39%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-09
Form 8-K
ID: 0000899923-24-000048
2024-09-04
Form 8-K
ID: 0000899923-24-000045
2024-08-07
Form 10-Q
ID: 0000899923-24-000041
2024-08-06
Form 8-K
ID: 0000899923-24-000036
2024-06-06
Form 8-K
ID: 0000899923-24-000028
2024-06-03
Form 8-K
ID: 0000899923-24-000027
2024-05-08
Form 10-Q
ID: 0000899923-24-000026
2024-05-07
Form 8-K
ID: 0000899923-24-000025
2024-02-27
Form 8-K
ID: 0000899923-24-000014
2024-01-16
Form 8-K
ID: 0000899923-24-000005